Should acute viral C hepatitis be treated with interferon?
Desai, H.G.; Gupte, P.A.
Indian Journal of Gastroenterology Official Journal of the Indian Society of Gastroenterology 24(2): 66-67
2005
ISSN/ISBN: 0254-8860 PMID: 15879653 Document Number: 589434
Document emailed within 1 workday
Related Documents
Stancek, D.; Fuchsberger, N.; Oltman, M.; Schmeisser, H.; Kontsek, P.; Jahnová, E.; Hajnická, V. 2001: Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virologica 45(5-6): 287-292Alscher, D.M.; Bode, J.C. 1992: Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha Medizinische Klinik 87(10): 532-539
Andreĭchin, M.A.; Rudchik, A.S.; Borak, V.F. 1988: Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B Terapevticheskii Arkhiv 60(11): 29-32
Suzuki, H.; Sata, M.; Noguchi, S.; Uchimura, Y.; Tanikawa, K. 1996: Acute hepatitis type C co-infected with GBV-C treated with interferon American Journal of Gastroenterology 91(12): 2651-2652
Pokrovskiĭ, V.I.; Zmyzgova, A.V.; Botsvadze, E.S.; Andreĭchin, M.A.; Frolov, V.M.; Murzabaeva, R.T.; Mesniankin, A.P.; Kokareva, L.N.; Malinovskaia, V.V. 1990: An assessment of the therapeutic efficacy of gene-engineered human alpha 2-interferon in patients with acute viral hepatitis B Terapevticheskii Arkhiv 62(2): 139-143
Singeisen, M.; Stalder, G.A.; Bianchi, L.; Gudat, F.; Schmid, M. 1977: Immunological aspects of acute viral hepatitis treated with corticosteroids Schweizerische Medizinische Wochenschrift 107(48): 1762-1764
Łapiński, T.W. 2001: Activation of acute phase proteins in patients with chronic hepatitis C treated with interferon-alpha 2a Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(57): 138-142
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Kokot, F.; Dobosz, J.; Kalińska, S.; Depta, T.; Bochenek, A.; Bodziony, J.; Piecuch, J.; Granicki, O. 1984: A case of acute hepatic encephalopathy caused by viral hepatitis and treated by arterialization of the portal blood Polski Tygodnik Lekarski 39(14): 471-472
Lisker Melman, M. 1990: Interferon system in viral hepatitis Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 42 Suppl: 92-96
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Pirovino, M. 1992: Interferon treatment of chronic viral hepatitis Therapeutische Umschau. Revue Therapeutique 49(5): 302-309
Wright, H.I. 1990: Interferon treatment of chronic viral hepatitis G.E.N 44(1): 71-77
Lin, S.M.; Chu, C.M.; Shih, L.Y.; Liaw, Y.F. 1991: Hematological abnormalities in acute viral hepatitis and acute hepatitis in HBsAg carrier Changgeng Yi Xue Za Zhi 14(4): 253-258
Dai, J.X.; You, C.H.; Qi, Z.T.; Wang, X.M.; Sun, P.Q.; Bi, W.S.; Qian, Y.; Ding, R.L.; Du, P.; He, Y. 1987: Children's respiratory viral diseases treated with interferon aerosol Chinese Medical Journal 100(2): 162-166
Beker, S.; Pujol, F.H.; Beker, B. 1995: Is the treatment of chronic viral hepatitis C with interferon-alpha effective? G.E.N 49(2): 165-169
Soriano, V.; García-Samaniego, J. 1994: Therapy with interferon in HIV-infected patients with chronic viral hepatitis Revista Clinica Espanola 194(10): 887-889
Bjøro, K.; Schrumpf, E.; Elgjo, K.; Nordgård, K. 1990: Chronic non-A non-B hepatitis treated with interferon Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(11): 1346-1348
Ettinger, O.A.; Nikitin, I.G.; Storozhakov, G.I. 1999: Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis Terapevticheskii Arkhiv 71(12): 69-72
Juszczyk, J.; Baka-Cwierz, B.; Beniowski, M.; Berak, H.; Bolewska, B.; Boroń-Kaczmarska, A.; Cianciara, J.; Cieśla, A.; Dziambor, A.; Gasiorowski, J.; Gietka, A.; Gliwińska, E.; Gładysz, A.; Gonciarz, Z.; Halota, W.; Horban, A.; Inglot, Młgorzata.; Janas-Skulina, U.; Janczewska-Kazek, E.; Jaskowska, J.; Jurczyk, K.; Knysz, B.; Kryczka, Wław.; Kuydowicz, J.; Lakomy, E.A.; Logiewa-Bazger, B.; Lyczak, A.; Mach, T.; Mazur, Włodzimierz.; Michalska, Z.; Modrzewska, R.; Nazzal, K.; Pabjan, Pł.; Piekarska, A.; Piszko, Pł.; Sikorska, K.; Szamotulska, K.; Sliwińska, M 2005: Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report) Przeglad Epidemiologiczny 59(3): 651-660